Jazz Pharmaceuticals plc (JAZZ) insider trading

By person

20 insiders · 3 transactions

31.5×

Renee D. Gala holds 31.5 times base salary in stock. $31.64M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Renee D. Gala last reported holding, valued at $225.37, the price Ordinary Shares was last bought or sold at on the open market here, on 3 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bruce C Cozadd

Director

—

$1.30M (1) scheduled

−$1.30M

339,875

0.5236%

$76.60M

−20.2%

Renee D Gala

President & CEO

—

$698.17K (2) scheduled

−$698.17K

140,394

0.2163%

$31.64M

+150.8%

Seamus Mulligan

Director

—

1,286,254

1.98%

$289.88M

+9.4%

Robert Iannone

EVP, Global Head of R&D & CMO

—

65,686

0.1012%

$14.80M

+4.8%

Philip L Johnson

EVP & Chief Financial Officer

—

56,431

0.0869%

$12.72M

+97.5%

Neena M Patil

EVP & Chief Legal Officer

—

47,671

0.0734%

$10.74M

+28.1%

Samantha Pearce

EVP, Chief Commercial Officer

—

47,131

0.0726%

$10.62M

+90.7%

Kenneth W O'Keefe

Director

—

25,811

0.0398%

$5.82M

+4.4%

Mary Elizabeth Henderson

SVP, Technical Operations

—

23,815

0.0367%

$5.37M

+63.9%

Patrick G Enright

Director

—

21,278

0.0328%

$4.80M

−13.8%

Heather Ann McSharry

Director

—

18,199

0.0280%

$4.10M

−3.7%

Norbert G Riedel

Director

—

17,553

0.0270%

$3.96M

+10.0%

Anne ORiordan

Director

—

16,500

0.0254%

$3.72M

+11.5%

Jennifer E. Cook

Director

—

10,736

0.0165%

$2.42M

+17.5%

Mark Douglas Smith

Director

—

9,579

0.0148%

$2.16M

+4.9%

Rick E Winningham

Director

—

9,466

0.0146%

$2.13M

−25.4%

Laura Hamill

Director

—

6,832

0.0105%

$1.54M

+30.6%

Patricia Carr

SVP, Chief Accounting Officer

—

6,512

0.0100%

$1.47M

−5.3%

Patrick Kennedy

Director

—

6,452

0.0099%

$1.45M

+25.2%

Ted W Love

Director

—

2,389

0.0037%

$538.41K

—

Jazz Pharmaceuticals plc

What the insiders did Scheduled selling only

By person